Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Non Operating Income (2016 - 2025)

Assembly Biosciences has reported Non Operating Income over the past 11 years, most recently at $2.3 million for Q4 2025.

  • Quarterly results put Non Operating Income at $2.3 million for Q4 2025, up 104.37% from a year ago — trailing twelve months through Dec 2025 was $6.0 million (up 7.59% YoY), and the annual figure for FY2025 was $6.0 million, up 7.59%.
  • Non Operating Income for Q4 2025 was $2.3 million at Assembly Biosciences, up from $1.7 million in the prior quarter.
  • Over the last five years, Non Operating Income for ASMB hit a ceiling of $2.3 million in Q4 2025 and a floor of $58000.0 in Q1 2021.
  • Median Non Operating Income over the past 5 years was $618500.0 (2023), compared with a mean of $817200.0.
  • Biggest five-year swings in Non Operating Income: crashed 94.42% in 2021 and later skyrocketed 757.75% in 2023.
  • Assembly Biosciences' Non Operating Income stood at $101000.0 in 2021, then soared by 477.23% to $583000.0 in 2022, then skyrocketed by 178.22% to $1.6 million in 2023, then plummeted by 30.89% to $1.1 million in 2024, then surged by 104.37% to $2.3 million in 2025.
  • The last three reported values for Non Operating Income were $2.3 million (Q4 2025), $1.7 million (Q3 2025), and $895000.0 (Q2 2025) per Business Quant data.